Re: Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind combination of avodart and tamsulosin (CombAT) trial

Steven A. Kaplan

doi:10.1016/j.juro.2011.10.105

Re: Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind combination of avodart and tamsulosin (CombAT) trial

Steven A. Kaplan

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	583-584
Number of pages	2
Journal	Journal of Urology
Volume	187
Issue number	2
DOIs	https://doi.org/10.1016/j.juro.2011.10.105
State	Published - Feb 2012

Access to Document

10.1016/j.juro.2011.10.105

Cite this

Kaplan, S. A. (2012). Re: Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind combination of avodart and tamsulosin (CombAT) trial. Journal of Urology, 187(2), 583-584. https://doi.org/10.1016/j.juro.2011.10.105

@article{4690d1f3e1d8484c84380fc11566c320,

title = "Re: Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind combination of avodart and tamsulosin (CombAT) trial",

author = "Kaplan, {Steven A.}",

year = "2012",

month = feb,

doi = "10.1016/j.juro.2011.10.105",

language = "English",

volume = "187",

pages = "583--584",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "2",

}

Kaplan, SA 2012, 'Re: Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind combination of avodart and tamsulosin (CombAT) trial', Journal of Urology, vol. 187, no. 2, pp. 583-584. https://doi.org/10.1016/j.juro.2011.10.105

Re: Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind combination of avodart and tamsulosin (CombAT) trial. / Kaplan, Steven A.
In: Journal of Urology, Vol. 187, No. 2, 02.2012, p. 583-584.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Re

T2 - Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind combination of avodart and tamsulosin (CombAT) trial

AU - Kaplan, Steven A.

PY - 2012/2

Y1 - 2012/2

UR - http://www.scopus.com/inward/record.url?scp=84855572538&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2011.10.105

DO - 10.1016/j.juro.2011.10.105

M3 - Comment/debate

AN - SCOPUS:84855572538

SN - 0022-5347

VL - 187

SP - 583

EP - 584

JO - Journal of Urology

JF - Journal of Urology

IS - 2

ER -